POST Online Media Lite Edition


Gilead Sciences sues U.S.: They secretly obtained patents on HIV research

Christian Fernsby |
Gilead Sciences has accused the U.S. government of breaching several contracts and secretly obtaining patents stemming from research that led to the ground-breaking Truvada HIV-prevention pill.

Article continues below

Topics: GILEAD SCIENCES    U.S.   

In a lawsuit filed late Friday, the drug maker claimed the Centers for Disease Control and Prevention violated the terms of a 15-year-old collaboration by failing to notify the company of patents that were later sought and awarded on the research.

What to read next

Gilead Sciences and Galapagos enter $5.05 billion, 10-year collaboration
Gilead to pay up to $1.2 billion for Nimbus unit, drug candidate
Gilead Sciences to acquire Kite Pharma for $11.9 billion